Targeting adaptive survival under stress
NextAge focuses on stress-response biology that allows cancer cells to persist through therapy, enabling relapse and resistance. Our platform is designed to identify and drug actionable control nodes within these adaptive systems.
What we address
Stress tolerance
Programs that preserve viability under hypoxia, metabolic constraint, and genotoxic stress.
Persistence biology
Mechanisms that support minimal residual disease and long-term survival under treatment.
Escape pathways
Adaptive rewiring that enables tumors to withstand targeted and cytotoxic therapies.
How the platform works
Map survival circuitry
Define control nodes that govern cellular state and stress adaptation in relevant contexts.
Prioritize druggability
Select targets and modalities that support strong chemical feasibility and translational strategy.
Enable combinations
Design programs that integrate into standard-of-care regimens to reduce escape.
We intentionally keep certain mechanistic details non-public to protect intellectual property.
Program characteristics
First-in-class potential
Novel biology with differentiated mechanism and strong strategic optionality.
Biomarker strategy
Designed for clear patient selection hypotheses and early pharmacodynamic readouts.
Translational robustness
Focus on clinically relevant endpoints tied to persistence and therapy resistance.